We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+1.22%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$11.6B
AUM Growth
+$425M
Cap. Flow
-$83.3M
Cap. Flow %
-0.72%
Top 10 Hldgs %
47.18%
Holding
586
New
15
Increased
41
Reduced
216
Closed
26

Top Buys

Rank Stock Value
1
VEEV icon
Veeva Systems
VEEV
+$9.76M
2
NVO
Novo Nordisk
NVO
+$8.82M
3
NVDA icon
NVIDIA
NVDA
+$8.78M
4
SNPS icon
Synopsys
SNPS
+$7.97M
5
DKS icon
Dick's Sporting Goods
DKS
+$3.26M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$10.2M
2
MA icon
Mastercard
MA
+$9.49M
3
FISV
Fiserv Inc
FISV
+$7M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
EOG icon
EOG Resources
EOG
+$5.55M

Sector Composition

Rank Sector Weight
1 Technology 38.56%
2 Healthcare 16.29%
3 Consumer Discretionary 11.3%
4 Financials 10.86%
5 Communication Services 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONON icon
426
On Holding
ONON
$10.3B
$35.3K ﹤0.01%
590
OXY.WS icon
427
Occidental Petroleum Corp Warrants
OXY.WS
$33.7B
0
KIM icon
428
Kimco Realty
KIM
$16.3B
$35K ﹤0.01%
1,492
TTEK icon
429
Tetra Tech
TTEK
$9.11B
$34.7K ﹤0.01%
900
UGI icon
430
UGI
UGI
$7.52B
$33.9K ﹤0.01%
1,102
VSTM icon
431
Verastem
VSTM
$617M
$33.9K ﹤0.01%
5,949
RWO icon
432
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.29B
$33K ﹤0.01%
750
VTR icon
433
Ventas
VTR
$46.2B
$30.9K ﹤0.01%
500
WAB icon
434
Wabtec
WAB
$50B
$30.9K ﹤0.01%
151
-40
-21% -$7.74K
PSA icon
435
Public Storage
PSA
$60.8B
$29.7K ﹤0.01%
100
WMS icon
436
Advanced Drainage Systems
WMS
$10.7B
$29.1K ﹤0.01%
233
CASY icon
437
Casey's General Stores
CASY
$31.5B
$28.1K ﹤0.01%
67
SLB icon
438
SLB Ltd
SLB
$77.3B
$28.1K ﹤0.01%
660
TOL icon
439
Toll Brothers
TOL
$14B
$28K ﹤0.01%
200
DUK icon
440
Duke Energy
DUK
$96.8B
$27K ﹤0.01%
240
GSK icon
441
GSK
GSK
$101B
$27K ﹤0.01%
760
MMM icon
442
3M
MMM
$94.1B
$26.5K ﹤0.01%
175
-350
-67% -$45.9K
UNB icon
443
Union Bankshares
UNB
$120M
$23.7K ﹤0.01%
775
-100
-11% -$3.02K
OGN icon
444
Organon & Co
OGN
$3.6B
$23.2K ﹤0.01%
1,427
-1
-0.1% -$16
FMS icon
445
Fresenius Medical Care
FMS
$12.6B
$22.8K ﹤0.01%
926
BNTX icon
446
BioNTech
BNTX
$23.2B
$22.8K ﹤0.01%
190
CDZI icon
447
Cadiz
CDZI
$298M
$22.1K ﹤0.01%
5,000
PHYS icon
448
Sprott Physical Gold
PHYS
$15.8B
$21.3K ﹤0.01%
1,008
PAGS icon
449
PagSeguro Digital
PAGS
$2.43B
$21.1K ﹤0.01%
3,010
IBB icon
450
iShares Biotechnology ETF
IBB
$9.83B
$20.8K ﹤0.01%
150

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Loring Wolcott & Coolidge Fiduciary Advisors held 586 positions worth $11.6B, up 3.8% from $11.2B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2024 filing shows 15 new, 41 increased, 216 reduced and 26 closed positions. Its largest new stake was KKR & Co: 15,000 shares worth $2.42M. The largest sale was Cigna, an estimated $10.2M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2024 buy was KKR & Co: 15,000 shares worth $2.42M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Veeva Systems in Q4 2024, an estimated $9.76M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2024 reduction was Cigna, cutting an estimated $10.2M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $151K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 47% of its $11.6B portfolio in Q4 2024.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 15 new positions and closed 26 in Q4 2024.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 3.8% quarter-over-quarter to $11.6B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2024, filed 28 Jan 2025.